Calcium Regulation in Osteoclasts

破骨细胞中的钙调节

基本信息

项目摘要

Healthy bone maintains a balance of bone formation mediated by osteoblasts and bone resorption mediated by osteoclasts. Many disease states, including chronic periodontitis, osteoporosis, rheumatoid arthritis, Paget's disease, and cancer metastases develop when osteoclasts are excessively recruited or inappropriately activated. Osteoclasts are constantly made throughout life from hematopoietic stem cells residing in the bone marrow through a series of complex events involving cytokine signaling and the microenvironment. Ca2+ signaling has an essential role in the regulation of osteoclastogenesis. Ca2+ channels activated in response to the depletion of intracellular Ca2+ stores have been suggested to mediate Ca2+ signaling in early stages of osteoclast formation. However, the exact molecules and the mechanism by which these channels control Ca2+ signaling in osteoclastogenesis are largely unknown. Using a combination of molecular, cell biological and whole animal studies, we show that the Transient Receptor Potential channel, TRPC1, enhances osteoclastogenesis at an early stage, whereas its inhibitor, the small cytosolic protein, I-mfa has an opposite effect. Enhanced osteoclastogenesis in I-mfa-null mice is corrected in mice lacking both genes indicating that TRPC1-mediated Ca2+ signaling has a dominant effect over I-mfa in osteoclast formation. Therefore, we propose that TRPC1 and I-mfa are essential for osteoclastogenesis by regulating Ca2+ signaling. This hypothesis will be tested by an integrated approach at the molecular, biophysical, cellular, and organismal levels by asking whether and how TRPC1 and I-mfa affect proliferation and "priming" of early osteoclast progenitors (specific aim 1), how TRPC1 and I-mfa modulate Ca2+ signaling in osteoclasts (specific aims 2 and 3), and whether TRPC1 and I-mfa affect osteoclastogenesis in a cell-autonomous fashion in vivo and in vitro and further, whether they affect osteoclast recruitment in experimentally induced animal models of osteoclastogenesis (specific aim 4). Our studies will lead to further understanding of critical pathways in the regulation of osteoclast development and function, which is needed to identify and develop new therapeutic interventions to control osteoclastogenesis and prevent bone loss.
健康的骨骼维持由成骨细胞介导的骨形成和由成骨细胞介导的骨吸收的平衡 破骨细胞。许多疾病状态,包括慢性牙周炎、骨质疏松症、类风湿性关节炎、佩吉特氏病 当破骨细胞过度募集或不当时,疾病和癌症转移就会发生 活性。破骨细胞在整个生命过程中不断由骨骼中的造血干细胞产生 骨髓通过涉及细胞因子信号传导和微环境的一系列复杂事件来发挥作用。钙离子 信号传导在破骨细胞生成的调节中具有重要作用。 Ca2+ 通道响应激活 细胞内 Ca2+ 储备的耗尽被认为在早期阶段介导 Ca2+ 信号传导 破骨细胞形成。然而,这些通道控制 Ca2+ 的确切分子和机制 破骨细胞生成中的信号传导在很大程度上是未知的。结合分子、细胞生物学和 在整个动物研究中,我们发现瞬时受体电位通道 TRPC1 可以增强 破骨细胞生成处于早期阶段,而其抑制剂,小胞质蛋白 I-mfa 则具有相反的作用 影响。 I-mfa 缺失小鼠中增强的破骨细胞生成在缺乏这两种基因的小鼠中得到纠正,表明 TRPC1 介导的 Ca2+ 信号传导在破骨细胞形成中比 I-mfa 具有主导作用。因此,我们 提出 TRPC1 和 I-mfa 通过调节 Ca2+ 信号传导对于破骨细胞生成至关重要。这 假设将通过分子、生物物理、细胞和有机体的综合方法进行检验 通过询问 TRPC1 和 I-mfa 是否以及如何影响早期破骨细胞的增殖和“启动”来了解 TRPC1 和 I-mfa 的水平 祖细胞(具体目标 1),TRPC1 和 I-mfa 如何调节破骨细胞中的 Ca2+ 信号传导(具体目标 2 和 3),以及TRPC1和I-mfa是否在体内和体外以细胞自主方式影响破骨细胞生成 此外,它们是否影响实验诱导的动物模型中破骨细胞的募集 破骨细胞生成(具体目标 4)。我们的研究将导致对关键途径的进一步了解 破骨细胞发育和功能的调节,这是识别和开发新治疗方法所必需的 控制破骨细胞生成和预防骨质流失的干预措施。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mary Beth Humphrey其他文献

735 - Vagal Nerve Stimulation Mitigates Pain in Mouse Models of Post-Traumatic Osteoarthritis
  • DOI:
    10.1016/j.joca.2024.02.750
  • 发表时间:
    2024-04-01
  • 期刊:
  • 影响因子:
  • 作者:
    Mary Beth Humphrey;Shivmurat Yadav;Monika Niewiadomska;Lynsie Morris;Taylor Connor;Jessica Lumry;Sanique South;Emmaline Prinz;Stavros Stavrakis;Matlock Jeffries;Timothy Griffin
  • 通讯作者:
    Timothy Griffin
Exercise induces dynamic changes in intra-articular metabolism and inflammation associated with remodeling of the infrapatellar fat pad in mice
运动可引起小鼠髌下脂肪垫重塑相关的关节内代谢和炎症的动态变化
  • DOI:
    10.1038/s41598-025-86726-0
  • 发表时间:
    2025-01-18
  • 期刊:
  • 影响因子:
    3.900
  • 作者:
    Timothy M. Griffin;Ravi K. Komaravolu;Erika Barboza Prado Lopes;Padmaja Mehta-D’souza;Taylor Conner;Tessa Kovats;Susan Kovats;Madeline Allen;Peyton Harris;Mary Beth Humphrey;Hope D. Welhaven;Priyanka Brahmachary;Ronald K. June
  • 通讯作者:
    Ronald K. June
Current Treatment for Glucocorticoid-Induced Osteoporosis: Beyond Bisphosphonates

Mary Beth Humphrey的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mary Beth Humphrey', 18)}}的其他基金

ShEEP Request for SCANCO microCT
SheEEP 请求 SCANCO microCT
  • 批准号:
    10738633
  • 财政年份:
    2023
  • 资助金额:
    $ 41.65万
  • 项目类别:
BCCMA: Targeting Osteoarthritis Pain and Progression: Preclinical OA models of vagal nerve stimulation to reduce pain and progression of OA
BCCMA:针对骨关节炎疼痛和进展:通过刺激迷走神经来减轻骨关节炎疼痛和进展的临床前 OA 模型
  • 批准号:
    10485419
  • 财政年份:
    2022
  • 资助金额:
    $ 41.65万
  • 项目类别:
Calcium Regulation in Osteoclasts
破骨细胞中的钙调节
  • 批准号:
    8737008
  • 财政年份:
    2013
  • 资助金额:
    $ 41.65万
  • 项目类别:
Calcium Regulation in Osteoclasts
破骨细胞中的钙调节
  • 批准号:
    8913682
  • 财政年份:
    2013
  • 资助金额:
    $ 41.65万
  • 项目类别:
Calcium Regulation in Osteoclasts
破骨细胞中的钙调节
  • 批准号:
    9353297
  • 财政年份:
    2013
  • 资助金额:
    $ 41.65万
  • 项目类别:
UNDERSTANDING THE ROLE OF ALTERNATIVE SPLICING IN THE TNFAIP3 SLE-RISK ALLELES
了解选择性剪接在 TNFAIP3 SLE 风险等位基因中的作用
  • 批准号:
    8359795
  • 财政年份:
    2011
  • 资助金额:
    $ 41.65万
  • 项目类别:
UNDERSTANDING THE ROLE OF ALTERNATIVE SPLICING IN THE TNFAIP3 SLE-RISK ALLELES
了解选择性剪接在 TNFAIP3 SLE 风险等位基因中的作用
  • 批准号:
    8168263
  • 财政年份:
    2010
  • 资助金额:
    $ 41.65万
  • 项目类别:
SHIP1 REGULATION OF DAP12 IN OSTEOCLAST DEVELOPMENT AND FUNCTION
SHIP1 对 DAP12 对破骨细胞发育和功能的调节
  • 批准号:
    7960579
  • 财政年份:
    2009
  • 资助金额:
    $ 41.65万
  • 项目类别:
Mechanism of ITAM Signal Regulation in Osteoclasts
破骨细胞ITAM信号调控机制
  • 批准号:
    8305426
  • 财政年份:
    2008
  • 资助金额:
    $ 41.65万
  • 项目类别:
Mechanism of ITAM Signal Regulation in Osteoclasts
破骨细胞ITAM信号调控机制
  • 批准号:
    7906881
  • 财政年份:
    2008
  • 资助金额:
    $ 41.65万
  • 项目类别:

相似海外基金

Double Incorporation of Non-Canonical Amino Acids in an Animal and its Application for Precise and Independent Optical Control of Two Target Genes
动物体内非规范氨基酸的双重掺入及其在两个靶基因精确独立光学控制中的应用
  • 批准号:
    BB/Y006380/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.65万
  • 项目类别:
    Research Grant
Quantifying L-amino acids in Ryugu to constrain the source of L-amino acids in life on Earth
量化 Ryugu 中的 L-氨基酸以限制地球生命中 L-氨基酸的来源
  • 批准号:
    24K17112
  • 财政年份:
    2024
  • 资助金额:
    $ 41.65万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: RUI: Elucidating Design Rules for non-NRPS Incorporation of Amino Acids on Polyketide Scaffolds
合作研究:RUI:阐明聚酮化合物支架上非 NRPS 氨基酸掺入的设计规则
  • 批准号:
    2300890
  • 财政年份:
    2023
  • 资助金额:
    $ 41.65万
  • 项目类别:
    Continuing Grant
Basic research toward therapeutic strategies for stress-induced chronic pain with non-natural amino acids
非天然氨基酸治疗应激性慢性疼痛策略的基础研究
  • 批准号:
    23K06918
  • 财政年份:
    2023
  • 资助金额:
    $ 41.65万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular mechanisms how arrestins that modulate localization of glucose transporters are phosphorylated in response to amino acids
调节葡萄糖转运蛋白定位的抑制蛋白如何响应氨基酸而被磷酸化的分子机制
  • 批准号:
    23K05758
  • 财政年份:
    2023
  • 资助金额:
    $ 41.65万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular recognition and enantioselective reaction of amino acids
氨基酸的分子识别和对映选择性反应
  • 批准号:
    23K04668
  • 财政年份:
    2023
  • 资助金额:
    $ 41.65万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Design and Synthesis of Fluorescent Amino Acids: Novel Tools for Biological Imaging
荧光氨基酸的设计与合成:生物成像的新工具
  • 批准号:
    2888395
  • 财政年份:
    2023
  • 资助金额:
    $ 41.65万
  • 项目类别:
    Studentship
Structurally engineered N-acyl amino acids for the treatment of NASH
用于治疗 NASH 的结构工程 N-酰基氨基酸
  • 批准号:
    10761044
  • 财政年份:
    2023
  • 资助金额:
    $ 41.65万
  • 项目类别:
Lifestyle, branched-chain amino acids, and cardiovascular risk factors: a randomized trial
生活方式、支链氨基酸和心血管危险因素:一项随机试验
  • 批准号:
    10728925
  • 财政年份:
    2023
  • 资助金额:
    $ 41.65万
  • 项目类别:
Single-molecule protein sequencing by barcoding of N-terminal amino acids
通过 N 端氨基酸条形码进行单分子蛋白质测序
  • 批准号:
    10757309
  • 财政年份:
    2023
  • 资助金额:
    $ 41.65万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了